The perfect business of the “Ozempic era”: weight-loss drugs, ultra-processed foods for weight gain
Un editorial de la revista ‘Science’ dibuja un futuro alimentario distópico modelado por los intereses cruzados de las industrias farmacéutica y alimentaria y sus estrategias de mercado
The conversation around obesity has shifted with the introduction of weight loss medications like Ozempic, Wegovy, and Mounjaro. These drugs have helped millions of people lose weight, leading to a change in perception, suggesting that obesity is a disease that can be treated with medication. However, this new perspective has its downsides and represents a significant business opportunity.
Written by urgent.news from El Pais's report — not a translation of it. Machine-written — may contain errors; check the original before relying on it.
